Individual holder
SALVATI MARK E
US·3 granted patents·1 pending application·2 citations·filing 2005–2012
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
4 records- 0171US8304403B2Heterocyclic CETP inhibitorsSALVATI MARK E·Filed 2010·Granted Nov 6, 2012·2 cites·17 claims
- 0254US8404896B2N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseasesSALVATI MARK E·Filed 2007·Granted Mar 26, 2013·0 cites·2 claims
- 0351US8642576B2Heterocyclic CETP inhibitorsSALVATI MARK E·Filed 2012·Granted Feb 4, 2014·0 cites·14 claims
- 0448US2005256048A1Selective androgen receptor modulators and methods for their identification, design and useSALVATI MARK E·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SALVATI MARK E files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →